Today, AB Nexus announced its fifth round of grant awards to researchers from the University of Colorado Anschutz Medical Campus and the University of Colorado Boulder. These teams are comprised of experts from a range of disciplines to advance basic science and translational research that improves human health and well-being, from taking on the most complex forms of cancer to exploring unexpected relationships between periodontal disease and stroke.
DENVER, Colo., Oct. 31, 2022 /PRNewswire/ – Birch Medical Spas (“Birch”), a newly launched medical spa platform, is excited to welcome Matt and Carrie Brinton and the Elase Medical Spas (“Elase”) team as its inaugural […]
A team of campus and system chief financial officers, representatives of the CU treasury and others is continuing its work to determine the impact of the financial market downturn and disconnects in information provided by […]
New 2-Month Interim Data from the ARCH Open Label Study of EDG-5506 in Individuals with Becker Muscular Dystrophy (BMD) to be Presented at the Upcoming New Directions in Biology and Disease of Skeletal Muscle Conference
BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for rare muscle disorders, today announced that new 2-month interim data from the ARCH open label […]